Eligibility criteria
Condition
Familial Hypercholesterolemia
Sex
Females and Males
Age
6-15 years
Inclusion criteria
Show details
- Heterozygous familial hypercholesterolemia, ages 6-15, LDL greater than 4 mmol/l
Exclusion criteria
Show details
- Active liver disease or hepatic dysfunction, or persistent elevations of serum
transaminases exceeding three times the upper limit of normal (ULN).
Female of childbearing potential who is not using adequate contraceptive measures or any
female who is pregnant or breastfeeding. Any female who becomes pregnant during study
participation will be immediately discontinued from treatment and counseled appropriately
about the in utero exposure.
Known hypersensitivities to HMG-CoA reductase inhibitors